Raymond James Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Raymond James Financial's AMGN Position: Q2 2026 in Review
Raymond James Financial reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $6.14M and leaving 1,602,419 shares worth $580M. The position accounts for 0.16% of the portfolio, ranked #107.
Raymond James Financial first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Raymond James Financial held 1,602,419 shares of Amgen worth $580M as of Q2 2026.
- Raymond James Financial sold 17,934 Amgen shares in Q2 2026, an estimated $6.14M.
- Amgen made up 0.16% of Raymond James Financial's portfolio in Q2 2026, its #107 holding.
- Raymond James Financial first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.